Abstract

Evidence-based recommendations on biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer in adults. This involves using a liquid gel or a balloon to increase the distance between the prostate and the rectum to reduce the amount of radiation reaching the rectum.

Next review: this guidance will be reviewed if there is new evidence or safety concerns.

Coding and clinical classification codes for this guidance

Guidance development process

How we develop NICE interventional procedures guidance